Blog Post I Major Cardiovascular Events and Biologics: What’s The Risk?
Friday, May 26, 2017
“A recent meta-analysis looked at 38 randomized controlled trials (RCTs) to examine the risk of MACEs in adult patients with plaque psoriasis that are exposed to biologic therapies. This was the largest meta-analysis to date and includes the newest biologics approved to treat plaque psoriasis.”
Read Full Blog on Dermcast.tv
|
|
Email to a Friend